Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data
Go back to Deutsche Bank Maintains Buy on Gilead Sciences (GILD) after Strong Hepatitis C Combo Data| Abbott Laboratories (NYSE: ABT) | Delayed: 88.28 -0.13 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.41 | 52 Week High | $46.38 | |||
| Open | $88.15 | 52 Week Low | $36.00 | |||
| Day High | $88.47 | P/E | 58.85 | |||
| Day Low | $87.21 | EPS | $1.50 | |||
| Volume | 3,169,456 | |||||
| Gilead Sciences (NASDAQ: GILD) | Delayed: 124.44 +0.68 (0.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $123.76 | 52 Week High | $108.63 | |||
| Open | $124.30 | 52 Week Low | $71.39 | |||
| Day High | $124.74 | P/E | 68.75 | |||
| Day Low | $123.00 | EPS | $1.81 | |||
| Volume | 2,326,789 | |||||
